Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
PHASE2
160 participants
INTERVENTIONAL
2020-02-01
2027-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Cannabis on Cigarette Use Behavior
NCT06609083
Clinical Trial Tobacco Marijuana
NCT02277665
Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders
NCT01834794
Young Adult Tobacco/Nicotine and Cannabis Co-use
NCT06239350
A Laboratory Model of Increasing Delta-9-tetrahydrocannabinol (THC) Potency on Cigarette Smoking
NCT02961309
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early-onset Cigarette Smokers
Participants who began smoking cigarettes earlier in life (\<16 years old) will be randomized to 7 or 21 days of tobacco cessation.
7 days of Tobacco Cessation
Participants will be randomly assigned to 7 days of tobacco cessation.
21 days of Tobacco Cessation
Participants will be randomly assigned to 21 days of tobacco cessation.
Cannabis
Participants will receive cannabis.
Late-onset Cigarette Smokers
Participants who began smoking cigarettes later in life (\>16 years old) will be randomized to 7 or 21 days of tobacco cessation.
7 days of Tobacco Cessation
Participants will be randomly assigned to 7 days of tobacco cessation.
21 days of Tobacco Cessation
Participants will be randomly assigned to 21 days of tobacco cessation.
Cannabis
Participants will receive cannabis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
7 days of Tobacco Cessation
Participants will be randomly assigned to 7 days of tobacco cessation.
21 days of Tobacco Cessation
Participants will be randomly assigned to 21 days of tobacco cessation.
Cannabis
Participants will receive cannabis.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Use cannabis
* Smoke tobacco cigarettes
* Medically and psychologically healthy
Exclusion Criteria
* Current pregnancy/lactation
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
New York State Psychiatric Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Margaret Haney
Professor of Psychiatry, Columbia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York State Psychiatric Institute
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7707
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.